Minke Whale Welfare: Commercial Whaling in Norway and Iceland

Commercial whaling of minke whales continues in Norway and Iceland. The welfare implications of whale killing methods are a central ethical concern in international whaling debates.

Key Facts

Norway kills around 500-600 minke whales annually under its self-allocated commercial whaling quota
Iceland resumed commercial whaling in 2006 after a moratorium period
The International Whaling Commission moratorium on commercial whaling has been in place since 1986
Whale grenades — explosive harpoons — are the primary killing method in commercial whaling
An estimated 20% of struck whales require a second shot before death
Instantaneous death rates in Norwegian whaling are estimated at around 80%, meaning 20% of whales suffer prolonged deaths

Welfare Considerations

Whale killing with explosive harpoons causes deaths that veterinary assessments describe as among the worst of any commercial killing method. Even when performed correctly, the time to death involves significant suffering in large, neurologically complex animals. The 20% secondary killing rate means approximately 100-120 whales annually in Norway alone experience prolonged suffering before death. Minke whales that escape with embedded harpoons face prolonged injury and potential death from infection. The cognitive complexity and social bonds of whales make the welfare significance of these deaths particularly acute. The commercial demand for whale products continues to shrink globally, reducing the economic justification for maintaining a welfare-problematic industry.

What You Can Do

Support IWC commercial whaling moratorium through organisations like WDC (Whale and Dolphin Conservation)
Avoid products from countries maintaining commercial whaling when alternatives exist
Advocate for your government to oppose commercial whaling resumption in international forums
Learn about cetacean cognition and welfare to understand the ethical dimensions of commercial whaling